Bioethics View All →

Ambiguity and American Domestic Health Policy: What is The Affordable Care Act and Who Cares?

Ambiguity and American Domestic Health Policy... (1 ver. 2)

By   3 years ago

“Affordable Care Act or Obama Care: which would you prefer?” Recent polls conducted by CNBC reveal that an additional 9% of participants oppose the law when the name of our president is attached, even though both refer to the same … Continue Reading

Read More →

U.S. Supreme Court Strikes Down Human Gene Patent

U.S. Supreme Court Strikes Down Human Gene Patent

By   3 years ago

It is no longer possible for companies to patent biological matter, regardless of whether the matter is within or removed from its natural state.

 

According to a recent ruling by the United States Supreme Court, “A naturally occurring DNA … Continue Reading

Read More →

The Ethics of Pharmaceutical Testing in the Developing World

The Ethics of Pharmaceutical Testing in the Developing World

By   3 years ago

In the last two decades, many pharmaceutical companies, including Bayer, GlaxoSmithKline, and Pfizer, have outsourced their clinical trials to developing countries, where testing is significantly cheaper and faster. Developing nations have welcomed drug testing as a mechanism to provide otherwise … Continue Reading

Read More →

A New Era of Stem Cell Research

A New Era of Stem Cell Research (1)

By   3 years ago

Nine months ago, the Supreme Court’s ruling on stem cell research redirected the path toward medical discovery. According to a recent article in the journal Nature, two stem cell researchers from the National Institute of Health filed a lawsuit intending … Continue Reading

Read More →

Refusing Medicine for Children

Refusing Medicine for Children

By   3 years ago

Medicine can be bad for us. Many drugs or treatments that are FDA-approved bring about a multitude of side effects, some potentially fatal, and it is within the rights of patients to refuse any treatment that they do not wish … Continue Reading

Read More →

Hot Topic: The Legalization of Marijuana

Marijuana

By   3 years ago

Whether or not the federal government should legalize marijuana has been heavily debated since the 1970s. Since the 1970s, minor marijuana offenses have been decriminalized in 11 states and penalties have been significantly lowered in all others. Today, there exists an extreme disconnect between federal and state laws and attitudes toward marijuana decriminalization and legalization. Read More →

Prosthetics and the paralympics

Oscar Pistorius

By   4 years ago

In the 2012 Summer Olympics, Oscar Pistorious became the first Olympic athlete to compete on prosthetic legs. As the field of prosthetics advances, might there be a point at which the effectiveness of adaptive sports equipment surpasses that of biological legs? Read More →

FDA may approve unlicensed genetic tests

23andMe

By   4 years ago

Personal genetics company 23andMe’s customers can track their ancestry and learn about their predispositions for diseases such as cancer and Alzheimer’s disease. 23andMe is now pushing for Food and Drug Administration approval of these tests, which can be purchased without the involvement of licensed clinicians. Read More →

Tips from the Past: The ancient Oriental medical art of acupuncture and its emergence in modern day alternative medicine

By   5 years ago

Needles are inserted at acupuncture points to relieve pain and other symptoms

Acupuncture is perhaps one of the most well-known alternative medicine treatments available in the United States today. It is considered legitimate enough to be able to be deducted … Continue Reading

Read More →

Chiropractic’s Contentious History as Alternative Care

By   5 years ago

Daniel David Palmer, founder of chiropractic medicine

For over a century, chiropractic has been a focal point of intense debate and skepticism in both the medical and non-medical communities.  Based on the practice of correcting misalignments in the spine via … Continue Reading

Read More →

    Recent View All →

    Op Ed: Indiana’s Innovative Medicaid Expansion and the Future Structure of Medicaid

    By   1 year ago

    When the Supreme Court ruled on the constitutionality of the Patient Protection and Affordable Care Act (ACA), also known as Obamacare, all eyes were on the individual mandate. When it survived the challenge, the law’s liberal supporters declared victory. Under

    Continue Reading
    Read More →

    Hospital Mergers & Antitrust Laws in the Age of the ACA

    By   1 year ago

    In 2010, President Obama signed the Affordable Care Act into law, changing the landscape of the American healthcare system forever. One of those changes constitutes an increase in hospital mergers and acquisitions by encouraging collaborative care; the ACA offers financial … Continue Reading

    Read More →

    The Global Debate Over Mass Deworming

    By   1 year ago

    The morning bell rings. One hundred children line up behind a desk.

    It’s National Deworming Day.

    One at a time, each child steps up and holds a hand out over the desk. A teacher drops a tablet into the child’s … Continue Reading

    Read More →

    Considering Connecticut Youth Forced Into Chemotherapy

    By   1 year ago

    In September 2014, a 17 year old Connecticut teenager identified in court documents only as “Cassandra C” was diagnosed with Hodgkin’s lymphoma, a rare form of cancer, and ordered by the state to undergo chemotherapy treatment for the disease. After … Continue Reading

    Read More →

    Systems of Physician Compensation: Time to Move From Fee-For-Service?

    By   1 year ago

    In 2005, the Wall Street Journal released an article detailing the events of a private meeting between a medical imaging company and the specialized physicians near its imaging center in a small California city. This private, for-profit imaging company laid … Continue Reading

    Read More →

    Breaking from the Herd: Struggling with Anti-Vaxxers

    By   1 year ago

    The first report came this year on January 7: seven confirmed cases of measles in Disneyland. Slowly the numbers rose. Then, there were twenty-six cases, twenty-two of which were linked to the original outbreak in Disneyland. By the beginning of … Continue Reading

    Read More →

    Perspectives on Medicaid Expansion

    By   1 year ago

    As the largest source of medical funding for people with low income, Medicaid has significant relevance to American lives. Compared to Medicare, a social insurance program designed to provide long-term care for the elderly, Medicaid is a social welfare program … Continue Reading

    Read More →

    King v. Burwell: How Potent is the Latest Threat to Obamacare?

    By   1 year ago

    On March 4th, 2015, the U.S. Supreme Court heard arguments for King v. Burwell, the latest case that threatens to derail the Affordable Care Act of 2010. The act was intended to reduce the number of uninsured people in two

    Continue Reading
    Read More →

    The Ethical and Economic Considerations of Advance Directives

    By   1 year ago

    As the population gets older and medical treatments afford the possibility of extending life even in the most fatal circumstances, organizing the end-of-life care system is imperative. The Hastings Center reports that 2.5 million Americans die per year, 70% of … Continue Reading

    Read More →

    Moral Distress Among Nurses

    By   2 years ago

    In the world of healthcare, professionals often come face-to-face with ethical dilemmas and stressful situations. Extensive research has been conducted to identify and mitigate these issues in the workplace. More recently, however, researchers have begun to study a different challenge … Continue Reading

    Read More →

      Cover Interviews View All →

      Interview with Yvette Fontenot

      Neha Anand - Interview with Yvette Fontenot, Ex-Deputy Director... - Avenue Solutions

      By   2 years ago

      Yvette Fontenot is a partner at Avenue Solutions, a democratic government affairs firm that offers strategic advice, policy development, and counsel in federal legislative and executive areas. She previously held the position of Deputy Director of the Office of Health Continue Reading

      Read More →

      How the Health Impact Fund is Tied to the American Pharmaceutical Industry: An Interview with Dr. Thomas Pogge

      How the Health Impact Fund is Tied to the American Pharmaceutical Industry - Yale University

      By   3 years ago

      Dr. Thomas Pogge is the Leitner Professor of Philosophy and International Affairs at Yale University. He is currently the Director of the Global Justice Program at Yale University’s MacMillan Center, which focuses on several projects including developing and implementing a … Continue Reading

      Read More →

      From Accidental to Transformational: An Interview with Pete Stark, Former Chair of the House Ways and Means Subcommittee on Heath Care

      An Interview with Congressman Pete Stark - Pete Stark

      By   3 years ago

      If you could define Pete Stark in one word, it would be accidental. According to Mr. Stark’s autobiography from his personal website, from being born eight months after his parents married to flunking out of MIT (and promptly returning) to … Continue Reading

      Read More →

      Interview with Dr. Mark Fishman ’72, President of the Novartis Institutes for BioMedical Research

      4819015388_c48c9bee0e_b

      By   3 years ago

      Dr. Mark Fishman ’72 is the President of the Novartis Institutes for BioMedical Research, the research branch of the pharmaceutical company Novartis. Before joining Novartis in 2002, Dr. Fishman was chief of cardiology and director of the Cardiovascular Research Center at Massachusetts General Hospital, as well as a medical professor at Harvard Medical School. Read More →

      Interview with Judith Krauss, Master of Silliman College

      By   4 years ago

      Judith B. Krauss, MSN, RN, FAAN is a Professor of Nursing at Yale University and Silliman College’s Master. She was the Founding Editor of Archives of Psychiatric Nursing, a practice, research and policy journal, and served as editor for 20 Continue Reading

      Read More →

      Interview with Dr. Francis Collins, Head of the National Institutes of Health

      By   5 years ago

      1. You were the director of the National Human Genome Research Institute and oversaw the Human Genome Project.  How has your background as a geneticist affected the way you approach managing the NIH and developing strategies to address national (and Continue Reading

      Read More →

      Interview with Dr. Stephen Oesterle

      By   6 years ago

      Stephen N. Oesterle, M.D., joined Medtronic in 2002 as its Senior Vice President for Medicine and Technology, overseeing the company’s scientific research, formation of technological strategies and continued development of strong cooperative relationships with the world's medical communities, such as

      Continue Reading
      Read More →

      Interview with Dr. Thomas R. Frieden MD MPH, Director, U.S. Centers for Disease Control and Prevention

      By   7 years ago


      Dr. Thomas R. Frieden was appointed Director of the U.S. Centers for Disease Control and Prevention (CDC) by President Barack Obama in May 2009. Pre¬viously, Dr. Frieden had been Commissioner of the New York City Health Department, since January 2002.

      Continue Reading
      Read More →

      Interview with Dr. Howard Forman, Founder of Yale University’s MD/MBA Program

      By   7 years ago


      Dr. Howard Forman is the founder and director of Yale University’s MD/MBA program. As a Professor of Diagnostic Radiology at the Yale School of Medicine and the Yale School of Management, Dr. Forman is a health services researcher focusing on

      Continue Reading
      Read More →

      Interview with Senator Sheldon Whitehouse (D-RI)

      By   8 years ago

      Sen. Sheldon Whitehouse (D-RI) ’78 was elected to the U.S. Senate in 2006, after serving as U.S. Attorney for Rhode Island and then as the state’s Attorney General. In these roles, he fought organized crime and public corruption and founded

      Continue Reading
      Read More →

        In the Courts View All →

        Hospital Mergers & Antitrust Laws in the Age of the ACA

        By   1 year ago

        In 2010, President Obama signed the Affordable Care Act into law, changing the landscape of the American healthcare system forever. One of those changes constitutes an increase in hospital mergers and acquisitions by encouraging collaborative care; the ACA offers financial … Continue Reading

        Read More →

        Considering Connecticut Youth Forced Into Chemotherapy

        By   1 year ago

        In September 2014, a 17 year old Connecticut teenager identified in court documents only as “Cassandra C” was diagnosed with Hodgkin’s lymphoma, a rare form of cancer, and ordered by the state to undergo chemotherapy treatment for the disease. After … Continue Reading

        Read More →

        King v. Burwell: How Potent is the Latest Threat to Obamacare?

        By   1 year ago

        On March 4th, 2015, the U.S. Supreme Court heard arguments for King v. Burwell, the latest case that threatens to derail the Affordable Care Act of 2010. The act was intended to reduce the number of uninsured people in two

        Continue Reading
        Read More →

        Abortion Legislation in Texas

        By   2 years ago

        On July 18, 2013, Texas Governor Rick Perry signed House Bill 2, “an act relating to the regulation of abortion procedures, providers, and facilities; providing penalties”, into law, introducing four new restrictions regarding abortion. The first regulation prohibited all abortions … Continue Reading

        Read More →

        Obamacare in Limbo – Federal Courts Still Indecisive

        By   2 years ago

        Only two years removed from a monumental ruling, the Affordable Care Act (ACA) is headed back to the Supreme Court.

        While its last trial revolved around the constitutionality of a presidential mandate, Obamacare is now under fire for a provision … Continue Reading

        Read More →

        U.S. Supreme Court Strikes Down Human Gene Patent

        U.S. Supreme Court Strikes Down Human Gene Patent

        By   3 years ago

        It is no longer possible for companies to patent biological matter, regardless of whether the matter is within or removed from its natural state.

         

        According to a recent ruling by the United States Supreme Court, “A naturally occurring DNA … Continue Reading

        Read More →

        A New Era of Stem Cell Research

        A New Era of Stem Cell Research (1)

        By   3 years ago

        Nine months ago, the Supreme Court’s ruling on stem cell research redirected the path toward medical discovery. According to a recent article in the journal Nature, two stem cell researchers from the National Institute of Health filed a lawsuit intending … Continue Reading

        Read More →

        Assisted Suicide and the Withdrawal of Life-Sustaining Treatment

        story-suicide-1107

        By   3 years ago

        In an era of aging populations, advancing medical care, and soaring end of life medical expenses, the ethical and moral implications of end of life treatment are forced into the forefront of bioethical debate. From this arises the inevitable question … Continue Reading

        Read More →

        Frivolous Lawsuits and How We Perceive Them

        By   5 years ago

        Photo credit: Peter π/FLICKR

        Frivolous lawsuits in the American legal system make rousing news stories and attention-grabbing headlines. They are usually health-related cases in which the plaintiff accuses the defendants of significant mental and physical damages. However, many are not … Continue Reading

        Read More →

        Malpractice Lawsuits in the US: Trends over Time and How Recent Reductions in Damage Awards Could Change Medicine

        By   5 years ago

        A physician by the name of Dr. Richard Viscarello walked into the delivery room of the Maternal Fetal Care clinic in Stamford, CT on Februrary 2, 2003 to perform a routine procedure, according to a 2011 article written by Matthew … Continue Reading

        Read More →

          Pharmaceuticals View All →

          Are Multivitamins Worth It?

          DCF 1.0

          By   2 years ago

          “I think it’s important,” my friend insisted as he swallowed a vitamin that looked a lot like a gummy bear, “Cover your bases, you know.” Indeed the logic behind supplementary vitamin use seems sound at first glance. The idea is … Continue Reading

          Read More →

          High Pharmaceutical Prices More Than Supply and Demand

          Kevin Ig-Izevbekhai - Why Drugs Are So Expensive - Celina Chiodo

          By   2 years ago

          In October 2012, doctors at Memorial Sloan-Kettering Cancer Center released a statement to the New York Times indicating that they would opt out of administering a new drug to their patients. They argued that at $11,063 a month, the drug … Continue Reading

          Read More →

          Pharmaceutical Copying: Patent Conflicts in the Developing World

          Neha Anand - Pharmaceutical Copying Patent Conflicts in the... - Audrey Luo (1280x1280)

          By   2 years ago

          Increases in the price of pharmaceuticals sold by companies like Bayer and Pfizer have driven developing countries to develop cheaper and more accessible drug copies. The World Health Organization estimates that low and middle-income countries have only 35% of the … Continue Reading

          Read More →

          The Ethics of Pharmaceutical Testing in the Developing World

          The Ethics of Pharmaceutical Testing in the Developing World

          By   3 years ago

          In the last two decades, many pharmaceutical companies, including Bayer, GlaxoSmithKline, and Pfizer, have outsourced their clinical trials to developing countries, where testing is significantly cheaper and faster. Developing nations have welcomed drug testing as a mechanism to provide otherwise … Continue Reading

          Read More →

          Drug Discovery and Research Institutions

          University Research

          By   3 years ago

          Drug discovery has been, for the most part, a traditionally industrial conquest. Medical research through industry provides a direct, goal-oriented approach to investigating new molecules. By contrast, academic research primarily consists of basic research and focuses on scientific understanding over practicality. Partially due to the Bayh-Dole Act of 1980, which allows universities to use federal funding for research while retaining patent rights, the pharmaceutical world has begun to be shared by both industrial research and academic research. Read More →

          Dr. Average Joe: Self-medicating in the United States

          Prescription Bottle

          By   3 years ago

          In March of 2012, the U.S. Food and Drug Administration (FDA) began to explore the possibility of increasing the number of available over-the-counter (OTC) drugs, though no conclusion has been made regarding this topic. The people we once called patients, but should now more appropriately call consumers, will have access to a large numbers of drugs that previously required a prescription. Read More →

          The FDA and Weight-Loss Drugs: Ensuring Consumer Freedom while Emphasizing Health Risks

          By   4 years ago

          Given the CDC estimate that over one-third of the U.S. adult population is obese, the availability of weight-loss drugs has been a controversial topic. According to the Mayo Clinic, weight-loss drugs are generally prescribed for patients with Body Mass … Continue Reading

          Read More →

          Eastern Medicine and Herbs: Treating the Individual

          By   5 years ago

          Ginseng, a common herb used in Eastern medicine, is often used to boost energy levels and stimulate thinking and memory.

          Given the growing popularity of eastern and alternative medicines as seen through their relatively steady demand in spite of the … Continue Reading

          Read More →

          The Growth of International Pharmaceuticals

          By   5 years ago

          This potential to create solutions to global health through sustainable entrepreneurship provides a much-needed response to previously ignored diseases.

          A new drug to treat HIV is set to be manufactured in Uganda early next year. Previously, HIV/AIDS patients relied primarily … Continue Reading

          Read More →

          The Rise of Consumer Directed Advertising

          By   6 years ago

          Over the past quarter-century, prescription drug manufacturers in the United States have increasingly invested in direct-to-consumer advertising (DTCA) designed to build brand recognition and foster patients’ belief in the quality of their products.

          DTCA is usually described as any promotional … Continue Reading

          Read More →

            Public Health View All →

            The Global Debate Over Mass Deworming

            By   1 year ago

            The morning bell rings. One hundred children line up behind a desk.

            It’s National Deworming Day.

            One at a time, each child steps up and holds a hand out over the desk. A teacher drops a tablet into the child’s … Continue Reading

            Read More →

            Breaking from the Herd: Struggling with Anti-Vaxxers

            By   1 year ago

            The first report came this year on January 7: seven confirmed cases of measles in Disneyland. Slowly the numbers rose. Then, there were twenty-six cases, twenty-two of which were linked to the original outbreak in Disneyland. By the beginning of … Continue Reading

            Read More →

            Climate Change and Public Health

            By   2 years ago

            Hundreds of thousands of people took to the streets of New York City on September 21, 2014 for the People’s Climate March, demanding global action to address climate change. The event took place two days before the UN Climate Summit, … Continue Reading

            Read More →

            The Challenge of Neonatal Addiction Syndrome

            By   2 years ago

            With a full head of hair tucked into a pastel blue cap and soft skin wrapped in a warm blanket, George looks like any normal baby. But unlike most at his young age, he has a morphine addiction. Stiff as … Continue Reading

            Read More →

            Ethics of Ebola Treatment

            By   2 years ago

            Ebola is a viral infection that attacks the dendritic cells of the immune system. These affected dendritic cells are unable to relay information about the viral attack, impairing the immune response. In a study released in August 2014 by Cell … Continue Reading

            Read More →

            Changing Organizational Culture to Improve Health Outcomes in U.S. Hospitals

            Adam Beckman - Improving Outcomes in U.S. Hospitals How... - stock.xchng

            By   2 years ago

            I. INTRODUCTION  Extreme deficits exist in the quality of healthcare provided by hospitals in the United States.  While several recent reports note improvements in select clinical areas,[i],[ii] researchers have shown that the U.S. healthcare system often fails … Continue Reading

            Read More →

            Cost Fixing and Loopholes

            Blue Scrub Woman

            By   3 years ago

            The recent activation of the Affordable Care and Patient Protection Act has had significant effects upon the current state of coverage, but many insurance company policies remain more or less unchanged. Although the ACA serves to aid in bringing down healthcare costs by targeting many private sector problems, a number of loopholes and exemptions have dampened and/or threaten to negate the effects of the reforms. Read More →

            Using telemedicine to address doctor shortages

            Telemedicine

            By   4 years ago

            Multiple technological advances enable doctors to treat patients far better than before, particularly in rural areas. How can we prevent technology from coming between the doctor and the patient? Read More →

            Syringe Exchange: Policy and Politics

            By   4 years ago

            Syringe exchange programs have been controversial since their inception in the 1980s at the height of the AIDS epidemic. Due to their association with marginalized populations, especially drug users and HIV/AIDS patients, syringe exchange programs have also been up for … Continue Reading

            Read More →

            The War on Cancer: A Focus on the Pink Battlefield

            By   4 years ago

            Since President Nixon declared the war on cancer in 1971, researchers have been executing countless strategies of attack to defeat this cunning and brutal enemy that kills roughly 1,500 people in the United States daily. Alongside the more traditional methods … Continue Reading

            Read More →
              • Current Issue